Literature DB >> 20217437

Association analysis of CbetaS 844ins68 and MTHFD1 G1958A polymorphisms with Alzheimer's disease in Chinese.

Xiu-Hua Bi1, Hua-Lu Zhao, Zhen-Xin Zhang, Qian Liu, Jun-Wu Zhang.   

Abstract

Folate deficiency and elevated plasma homocysteine play important roles in pathogenesis of Alzheimer's disease (AD). The aim of this study was to test the association of folate metabolism-related genes, cystathionine beta-synthase gene (CbetaS) and 5, 10-methylenetetrahydrofolate dehydrogenase gene (MTHFD1), with sporadic AD. The CbetaS 844ins68 polymorphism was determined by PCR and the MTHFD1 G1958A single nucleotide polymorphism (rs2236225) by PCR-RFLP. No significant difference of allele and genotype contributions of the CbetaS polymorphism between AD cases and controls was detected, before and after stratification by APOE epsilon4-carrying status, age/age at onset and genders. No significant difference of allele and genotype contributions of the MTHFD1 polymorphism between AD cases and controls was detected in total samples. When stratified by age/at onset age, we found that A allele and AA genotype frequencies in cases were higher than in controls and the differences were close to significant [A vs. G, P = 0.032, Odds ratio (OR) 1.642, 95% CI 1.040-2.591; AA + GA vs. GG, P = 0.068, OR 1.665, 95% CI 0.961-2.885; AA vs. GG, P = 0.059, OR 3.458, 95% CI 0.894-13.369] in <65 years groups, which suggested that the MTHFD1 G1958A A allele might be a weak risk factor for early onset AD although it needs further confirmation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20217437     DOI: 10.1007/s00702-010-0383-x

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  26 in total

1.  Alzheimer's disease and total plasma aminothiols.

Authors:  Andrew McCaddon; Peter Hudson; Diane Hill; Joan Barber; Alwyn Lloyd; Gareth Davies; Björn Regland
Journal:  Biol Psychiatry       Date:  2003-02-01       Impact factor: 13.382

2.  Homocysteine and folate as risk factors for dementia and Alzheimer disease.

Authors:  Giovanni Ravaglia; Paola Forti; Fabiola Maioli; Mabel Martelli; Lucia Servadei; Nicoletta Brunetti; Elisa Porcellini; Federico Licastro
Journal:  Am J Clin Nutr       Date:  2005-09       Impact factor: 7.045

3.  Confirmation of the R653Q polymorphism of the trifunctional C1-synthase enzyme as a maternal risk for neural tube defects in the Irish population.

Authors:  Anne Parle-McDermott; Peadar N Kirke; James L Mills; Anne M Molloy; Christopher Cox; Valerie B O'Leary; Faith Pangilinan; Mary Conley; Laura Cleary; Lawrence C Brody; John M Scott
Journal:  Eur J Hum Genet       Date:  2006-06       Impact factor: 4.246

4.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.

Authors:  J E Hixson; D T Vernier
Journal:  J Lipid Res       Date:  1990-03       Impact factor: 5.922

5.  Relation of higher folate intake to lower risk of Alzheimer disease in the elderly.

Authors:  José A Luchsinger; Ming-Xin Tang; Joshua Miller; Ralph Green; Richard Mayeux
Journal:  Arch Neurol       Date:  2007-01

6.  Genetic variation of folate-mediated one-carbon transfer pathway predicts susceptibility to choline deficiency in humans.

Authors:  Martin Kohlmeier; Kerry-Ann da Costa; Leslie M Fischer; Steven H Zeisel
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-18       Impact factor: 11.205

7.  Homocysteine and holo-transcobalamin and the risk of dementia and Alzheimers disease: a prospective study.

Authors:  M Kivipelto; S Annerbo; J Hultdin; L Bäckman; M Viitanen; L Fratiglioni; J Lökk
Journal:  Eur J Neurol       Date:  2009-04-21       Impact factor: 6.089

8.  Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland.

Authors:  Stephen P McIlroy; Kevin B Dynan; John T Lawson; Christopher C Patterson; A Peter Passmore
Journal:  Stroke       Date:  2002-10       Impact factor: 7.914

9.  Methylenetetrahydrofolate reductase and angiotensin converting enzyme gene polymorphisms in two genetically and diagnostically distinct cohort of Alzheimer patients.

Authors:  Davide Seripa; Gloria Dal Forno; Maria G Matera; Carolina Gravina; Maurizio Margaglione; Mark T Palermo; David R Wekstein; Piero Antuono; Daron G Davis; Antonio Daniele; Carlo Masullo; Alessandra Bizzarro; Massimo Gennarelli; Vito M Fazio
Journal:  Neurobiol Aging       Date:  2003-11       Impact factor: 4.673

10.  Liquid chromatographic determination of total homocysteine in blood plasma with photometric detection.

Authors:  Alexander A Zhloba; Eduard L Blashko
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2004-02-05       Impact factor: 3.205

View more
  4 in total

1.  Association between Hcy levels and the CBS844ins68 and MTHFR C677T polymorphisms with essential hypertension.

Authors:  Weijuan Cai; Liang Yin; Fang Yang; Lei Zhang; Jiang Cheng
Journal:  Biomed Rep       Date:  2014-09-05

2.  Folate Related Pathway Gene Analysis Reveals a Novel Metabolic Variant Associated with Alzheimer's Disease with a Change in Metabolic Profile.

Authors:  Jaleel Miyan; Charlotte Buttercase; Emma Beswick; Salma Miyan; Ghazaleh Moshkdanian; Naila Naz
Journal:  Metabolites       Date:  2022-05-24

3.  CpG-SNP site methylation regulates allele-specific expression of MTHFD1 gene in type 2 diabetes.

Authors:  Manik Vohra; Prabha Adhikari; Sydney C D' Souza; Shivashankar K Nagri; Shashikiran Umakanth; Kapaettu Satyamoorthy; Padmalatha S Rai
Journal:  Lab Invest       Date:  2020-04-01       Impact factor: 5.662

4.  Metabolic profiling of a transgenic Caenorhabditis elegans Alzheimer model.

Authors:  Roel Van Assche; Liesbet Temmerman; Daniel A Dias; Berin Boughton; Kurt Boonen; Bart P Braeckman; Liliane Schoofs; Ute Roessner
Journal:  Metabolomics       Date:  2014-07-30       Impact factor: 4.290

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.